Label: LAMISIL AT- terbinafine hydrochloride aerosol, spray
- Label RSS
- Share
- NDC Code(s): 0067-6296-01
- Packager: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated August 16, 2021
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient
- Purpose
- Uses
- Warnings
-
Directions
- •
- adults and children 12 years and over:
- •
- wash the affected area with soap and water and dry completely before applying
- •
- to open remove clear cap
- •
- hold can 4" to 6" from skin. Press and hold to spray a thin layer over affected area
- •
- spray affected area once a day (morning or night) for 1 week or as directed by a doctor
- •
- release to stop spray
- •
- wipe excess from spray opening after each use
- •
- return cap to can
- •
- for athlete’s foot between the toes spray twice a day (morning and night) for 1 week or as directed by a doctor. Wear well-fitting, ventilated shoes. Change shoes and socks at least once daily.
- •
- for jock itch and ringworm spray affected area once a day (morning or night) for 1 week or as directed by a doctor
- •
- wash hands after each use
- •
- children under 12 years: ask a doctor
- Other information
- Inactive ingredients
- Questions?
-
Principal Display Panel
NDC 0067-6296-01
TERBINAFINE HYDROCHLORIDE SOLUTION 1% - ANTIFUNGAL
LAMISILAT®SPRAY
Clinically proven to cure most athlete’s foot between the toes
Full prescription strength
Relieves itching, burning, cracking and scaling
Net Contents 125 ml (4.2 fl oz)
The only 1 week (twice a day)athlete’s foot spray
Trademarks are owned by or licensed to the GSK group of companies.
1-800-330-9876
Distributed by:
GSK Consumer Healthcare,
Warren, NJ 07059
©2017 GSK or its licensor.
13059
-
INGREDIENTS AND APPEARANCE
LAMISIL AT
terbinafine hydrochloride aerosol, sprayProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0067-6296 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TERBINAFINE HYDROCHLORIDE (UNII: 012C11ZU6G) (TERBINAFINE - UNII:G7RIW8S0XP) TERBINAFINE HYDROCHLORIDE 0.84 g in 125 mL Inactive Ingredients Ingredient Name Strength ALCOHOL (UNII: 3K9958V90M) POLYOXYL 20 CETOSTEARYL ETHER (UNII: YRC528SWUY) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0067-6296-01 125 mL in 1 CAN; Type 0: Not a Combination Product 03/07/2018 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021124 03/07/2018 Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263)
